| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/23/2013 | WO2013072265A1 1-pyridazinyl-hydroxyimino- 3- phenyl- propanes as gpbar1 agonists |
| 05/23/2013 | WO2013071715A1 Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments |
| 05/23/2013 | WO2013071396A1 Oral leptin formulations and uses thereof |
| 05/23/2013 | WO2013048989A3 Pyrazole compounds |
| 05/23/2013 | WO2013048158A3 Novel usage for eupatilin |
| 05/23/2013 | WO2012051318A8 Sulphonamide compounds and methods of making and using same |
| 05/23/2013 | US20130133092 Sequence-specific dna recombination in eukaryotic cells |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130131125 Therapeutic combination |
| 05/23/2013 | US20130131113 Pyridone glucokinase activators |
| 05/23/2013 | US20130131071 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 05/23/2013 | US20130131038 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | CA2856160A1 Composition comprising chicory extract |
| 05/23/2013 | CA2855770A1 Pegylated c-peptide |
| 05/23/2013 | CA2855759A1 Tricyclic compounds, compositions comprising them and uses thereof |
| 05/23/2013 | CA2855545A1 Oral leptin formulations and uses thereof |
| 05/23/2013 | CA2850584A1 1-pyridazinyl-hydroxyimino-3-phenyl-propanes as gpbar1 agonists |
| 05/23/2013 | CA2847246A1 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity |
| 05/22/2013 | EP2594570A1 Crystal of thienopyrimidine derivative |
| 05/22/2013 | EP2594565A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594564A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594563A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594562A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594555A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 05/22/2013 | EP2594281A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 05/22/2013 | EP2594277A1 Tablet containing ferric citrate |
| 05/22/2013 | EP2594275A1 Prophylactic or therapeutic agent for diabetes |
| 05/22/2013 | EP2593459A1 Process for the preparation of organic salts |
| 05/22/2013 | EP2593454A1 New azacyclic compounds |
| 05/22/2013 | EP2593126A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 05/22/2013 | EP2593125A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 05/22/2013 | EP2593124A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 05/22/2013 | EP2593093A1 Use of a cationic amphiphilic drug for the preparation of a formulation for the reduction of subcutaneous adipose tissue |
| 05/22/2013 | CN103119055A Pegylated C-Peptide |
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103119039A Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 05/22/2013 | CN103118696A Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases |
| 05/22/2013 | CN103118695A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| 05/22/2013 | CN103118693A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases |
| 05/22/2013 | CN103118692A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
| 05/22/2013 | CN103118683A Reconstituted high density lipoprotein formulation and production method thereof |
| 05/22/2013 | CN103118675A Fat and oil composition for promoting insulin secretion |
| 05/22/2013 | CN103118673A Fat-reducing agent |
| 05/22/2013 | CN103114024A Eyesight improving and blood pressure reducing health-care wine |
| 05/22/2013 | CN103114023A Preparation method of eyesight improving and blood pressure reducing health-care wine |
| 05/22/2013 | CN103113405A Benfotiamine polymorphism body, preparation method and application thereof |
| 05/22/2013 | CN103113360A Atorvastatin derivative, pharmaceutical composition and pharmaceutical applications thereof |
| 05/22/2013 | CN103113353A Triazole compounds, medical composition thereof and preparation and application of triazole compounds |
| 05/22/2013 | CN103113253A Alcohol amine derivative of unsaturated fatty acid and preparation method and application thereof |
| 05/22/2013 | CN103113202A (2E, 5E)-2, 5-benzal cyclopentanone analogue and preparation method and application thereof |
| 05/22/2013 | CN103110944A Methods of administering anti-TNF alpha antibodies |
| 05/22/2013 | CN103110934A Method for treating diabetic gangrene |
| 05/22/2013 | CN103110862A Traditional Chinese medicine composition for treating diabetes |
| 05/22/2013 | CN103110849A Traditional Chinese medicine pill for treating hyperlipidemia caused by stagnation of phlegm-dampness |
| 05/22/2013 | CN103110846A Traditional Chinese medical composition for treating hyperlipemia as well as preparation method and application thereof |
| 05/22/2013 | CN103110834A Process for extracting partina anglica general flavone through supercritical CO2 method |
| 05/22/2013 | CN103110825A Medicinal composition for treating diabetes and preparation method thereof |
| 05/22/2013 | CN103110815A Traditional Chinese medicine composition for treating type II diabetes and preparation method thereof |
| 05/22/2013 | CN103110809A Traditional Chinese medicine composition for treating diabetic constipation |
| 05/22/2013 | CN103110807A Medicine for treating diabetes |
| 05/22/2013 | CN103110721A Medicinal composition for treating diabetes |
| 05/22/2013 | CN103110718A Preparation for regulating metabolism, protecting liver as well as preventing and treating cardiovascular and cerebrovascular diseases |
| 05/22/2013 | CN103110703A Method and device for dynamically continuously and circularly extracting polygonum multiflorum |
| 05/22/2013 | CN103110698A Traditional Chinese medicine composition for treating diabetes and preparation method thereof |
| 05/22/2013 | CN103110697A Pharmaceutical composition with hypoglycemic effect |
| 05/22/2013 | CN103110687A Compound effervescent preparation containing soy isoflavone |
| 05/22/2013 | CN103110686A Medicine for treating diabetic retinopathy and preparation method of medicine |
| 05/22/2013 | CN103110676A Method and device for dynamically continuously and circularly extracting total ginsenoside contained in ginseng medicinal material |
| 05/22/2013 | CN103110659A Application of trepang sulphated polysaccharide in preparation of drugs or products for resisting diabetes mellitus II |
| 05/22/2013 | CN103110656A Water-soluble vitamin freeze-dried preparation for injection and preparation method thereof |
| 05/22/2013 | CN103110651A Application of active ingredient namely loganin in dogwood in preparation of medicaments for treating diabetes |
| 05/22/2013 | CN103110647A Pharmaceutical composition for fat-soluble vitamins |
| 05/22/2013 | CN103110640A Pharmaceutical composition of injection ceftizoxime sodium and compound amino acid injection |
| 05/22/2013 | CN103110626A Pharmaceutical composition and application thereof |
| 05/22/2013 | CN103110622A Solid oral agent containing voglibose and atorvastatin calcium and preparation method thereof |
| 05/22/2013 | CN103110618A Medical application of wogonin |
| 05/22/2013 | CN103110617A Application of diacerein to prepare medicine for treating diabetic nephropathy |
| 05/22/2013 | CN103110616A Potassium magnesium aspartate freeze-dried powder preparation for injection and preparation method of preparation |
| 05/22/2013 | CN103110615A Preparation method of microelement zinc-iron raw injection for pig |
| 05/22/2013 | CN103110606A Alfacalcidol capsules and preparation method thereof |
| 05/22/2013 | CN103110601A Gliclazide gastric floating tablet and preparation method thereof |
| 05/22/2013 | CN103110600A Metformin hydrochloride gastric floating tablet and preparation method thereof |
| 05/22/2013 | CN103110598A Alfacalcidol dispersible tablet and preparation method thereof |
| 05/22/2013 | CN103110594A Atorvastatin calcium nano freeze-dried powder and preparation method thereof |
| 05/22/2013 | CN103110588A Production method of vitamin B6 granules |
| 05/22/2013 | CN103110587A Alfacalcidol dry suspension and preparation method thereof |
| 05/22/2013 | CN103110515A Glucosamine potassium sulfate particle production method |
| 05/22/2013 | CN103110109A Radix isatidis VC tablet and preparation method |
| 05/22/2013 | CN102688187B Fructose medicament composition injection and preparation method thereof |
| 05/22/2013 | CN102512458B Semi-bionic extraction method for active components of cordyceps militaris |
| 05/22/2013 | CN102441019B Chinese medicinal chrysanthemum buccal tablet |
| 05/22/2013 | CN102423481B Medicine for treating diabetes and preparation method thereof |
| 05/22/2013 | CN102137844B Compounds and compositions as modulators of GPR119 activity |
| 05/22/2013 | CN102125566B Pharmaceutical composition comprising cycloartenyl ferulate |
| 05/22/2013 | CN102076670B Compounds and methods for modulating g protein-coupled receptors |
| 05/22/2013 | CN101897662B Ophtalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/22/2013 | CN101862331B New use of methyl liensinine |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/22/2013 | CN101622241B Benzimidazole compound and pharmaceutical use thereof |